Kidney Diagnostic Assays

About BioPAL

Founded in 2003 and based in Worcester, Massachusetts, BioPAL operates in the diagnostics and proteomics sectors, serving the life science research community with highly specialized tools. The company has built a portfolio around several niche technology platforms, including assays for accurate kidney function measurement, novel MRI contrast agents, and products for neutron activation analysis and cellular therapy research. BioPAL's business model is commercial, generating revenue through the sale of its diagnostic kits, imaging reagents, and custom conjugation services, positioning it as a provider of essential, hard-to-find research tools.

Therapeutic Areas